Search research articles
Contact Us
Filters
Showing results (191-200 of 252) with videos related to
Page
of 26
Sort By:
Intervirology
|
April 14, 2017
The Genotyping Resistance Profile of the Pol Gene Detected in Blood of Newly Diagnosed HIV-Positive Men Is Durably Archived in the Gut Whatever the Time of Initiation of cART
Anne Emmanuelle Depincé, Elodie Dussert, Delphine Vergnon-Miszczycha, et al.
Digestive Diseases and Sciences
|
January 2, 2021
Low Levels of Fecal Calprotectin 3 Months After Surgery Predict Subsequent Endoscopic Postoperative Remission in Crohn's Disease
Florian Veyre, Gilles Boschetti, Camille Meunier, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
September 15, 2018
Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Vedolizumab in Patients With Refractory Ulcerative Colitis
Gauthier Pellet, Carmen Stefanescu, Franck Carbonnel, et al.
Journal of Crohn'S & Colitis
|
May 17, 2019
Comparison of Adalimumab Serum Drug Levels When Delivered by Pen Versus Syringe in Patients With Inflammatory Bowel Disease. An International, Multicentre Cohort Analysis
Robert D Little, Isabel E Chu, Esmerij P van der Zanden, et al.
Journal of Crohn'S & Colitis
|
March 24, 2026
Personalized infliximab rescue therapy to maximize colectomy-free survival in patients with acute severe ulcerative colitis
Emmanuel Niyigena, Yannick Hoffert, Waqqas Afif, et al.
Lancet (London, England)
|
December 19, 2016
Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial
Séverine Vermeire, Stefan Schreiber, Robert Petryka, et al.
Journal of Autoimmunity
|
April 7, 2017
Vaccination recommendations for the adult immunosuppressed patient: A systematic review and comprehensive field synopsis
Anthony Lopez, Xavier Mariette, Hervé Bachelez, et al.
World Journal of Gastroenterology
|
March 23, 2022
Relationship between clinical remission of perianal fistulas in Crohn's disease and serum adalimumab concentrations: A multi-center cross-sectional study
Laura Sirmai, Anne-Laure Pelletier, Nathalie Gault, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
September 25, 2024
Patient Satisfaction and Experience with CT-P17 Following Transition from Reference Adalimumab or Another Adalimumab Biosimilar: Results from the Real-World YU-MATTER Study
Guillaume Bouguen, Laure Gossec, Vered Abitbol, et al.
BMC Gastroenterology
|
June 8, 2022
Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis
Laurent Peyrin-Biroulet, Perttu Arkkila, Alessandro Armuzzi, et al.
Page
of 26
Search research articles
Search
Showing results (191-200 of 252) with videos related to
Sort By:
Page
of 26
Intervirology
|
April 14, 2017
The Genotyping Resistance Profile of the Pol Gene Detected in Blood of Newly Diagnosed HIV-Positive Men Is Durably Archived in the Gut Whatever the Time of Initiation of cART
Anne Emmanuelle Depincé, Elodie Dussert, Delphine Vergnon-Miszczycha, et al.
Digestive Diseases and Sciences
|
January 2, 2021
Low Levels of Fecal Calprotectin 3 Months After Surgery Predict Subsequent Endoscopic Postoperative Remission in Crohn's Disease
Florian Veyre, Gilles Boschetti, Camille Meunier, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
September 15, 2018
Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Vedolizumab in Patients With Refractory Ulcerative Colitis
Gauthier Pellet, Carmen Stefanescu, Franck Carbonnel, et al.
Journal of Crohn'S & Colitis
|
May 17, 2019
Comparison of Adalimumab Serum Drug Levels When Delivered by Pen Versus Syringe in Patients With Inflammatory Bowel Disease. An International, Multicentre Cohort Analysis
Robert D Little, Isabel E Chu, Esmerij P van der Zanden, et al.
Journal of Crohn'S & Colitis
|
March 24, 2026
Personalized infliximab rescue therapy to maximize colectomy-free survival in patients with acute severe ulcerative colitis
Emmanuel Niyigena, Yannick Hoffert, Waqqas Afif, et al.
Lancet (London, England)
|
December 19, 2016
Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial
Séverine Vermeire, Stefan Schreiber, Robert Petryka, et al.
Journal of Autoimmunity
|
April 7, 2017
Vaccination recommendations for the adult immunosuppressed patient: A systematic review and comprehensive field synopsis
Anthony Lopez, Xavier Mariette, Hervé Bachelez, et al.
World Journal of Gastroenterology
|
March 23, 2022
Relationship between clinical remission of perianal fistulas in Crohn's disease and serum adalimumab concentrations: A multi-center cross-sectional study
Laura Sirmai, Anne-Laure Pelletier, Nathalie Gault, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
September 25, 2024
Patient Satisfaction and Experience with CT-P17 Following Transition from Reference Adalimumab or Another Adalimumab Biosimilar: Results from the Real-World YU-MATTER Study
Guillaume Bouguen, Laure Gossec, Vered Abitbol, et al.
BMC Gastroenterology
|
June 8, 2022
Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis
Laurent Peyrin-Biroulet, Perttu Arkkila, Alessandro Armuzzi, et al.
Page
of 26